BCL2L1 and non-small cell lung carcinoma: It effectively reduced mRNA and protein levels of p65 and p50, suppressed the NF-κB pathway’s transcriptional activity, decreased Bcl-xL protein abundance, and altered Cyclin D1 expression in non-small-cell lung cancer (NSCLC) cells.